Please use this identifier to cite or link to this item:
Type: Artigo
Title: Articaine (4%) with epinephrine (1:100,000 or 1:200,000) in intraosseous injections in symptomatic irreversible pulpitis of mandibular molars: anesthetic efficacy and cardiovascular effects
Author: Pereira, L. A. P.
Groppo, F. C.
Bergamaschi, C. C.
Meechan, J. G.
Ramacciato, J. C.
Motta, R. H. L.
Ranali, J.
Abstract: The aim of this study was to compare the cardiovascular effects and the anesthetic efficacy of intraosseous injections of 4% articaine with 1:100,000 epinephrine (EPI100) or 4% articaine with 1:200,000 epinephrine (EPI200). In this prospective, randomized, double-blind study, 0.9 mL EPI100 and EPI200 solutions were administered for endodontic treatment of mandibular molars with symptomatic irreversible pulpitis in 60 patients. The anesthetic success and pain during anesthesia were evaluated by visual analog scale. The cardiovascular parameters evaluated were heart rate, diastolic/systolic blood pressure, pulse oximetry, and electrocardiogram changes. Both solutions provided high anesthetic efficacy (96.8% and 93.1% for EPI100 and EPI200, respectively; P > .05), and the cardiovascular parameters showed minimal incidences of significant differences throughout the clinical procedure. The epinephrine concentration did not affect the efficacy of 4% articaine, and both solutions produced a high success level of pulpal anesthesia. Intraosseous delivery by slow speed of injection did not induce significant clinical changes in cardiovascular parameters
Subject: Carticaína
Anestésicos locais
Country: Estados Unidos
Editor: Elsevier
Citation: Oral Surgery Oral Medicine Oral Pathology Oral Radiology. Elsevier Science Inc, v. 116, n. 2, n. E85, n. E91, 2013.
Rights: fechado
Identifier DOI: 10.1016/j.oooo.2011.10.045
Date Issue: 2013
Appears in Collections:FOP - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000321737900002.pdf308.83 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.